Preview Genetic Report

Illustrative example of the DNA_CHECKS consumer genetics report

Example report — no real person's DNA

This public preview uses deliberately synthetic, illustrative results. It preserves the structure and visual language of a DNA_CHECKS report without reproducing the uploaded individual's personal genetic findings, genotypes, origin rankings, clinical results or pharmacogenomic calls.

Selected examples only. A full report is not limited to the example counts shown here. Sections expand independently according to the uploaded DNA file, usable marker coverage and the evidence that passes DNA_CHECKS' gates, so a finished report can be substantially denser than this preview.

About this preview

DNA_CHECKS interprets uploaded DNA as screening evidence. Important medical findings require independent confirmation before clinical use.
Origins, traits and association findings are informational rather than diagnostic.
This preview contains synthetic examples only. Nothing shown here should be interpreted as a result for any real person.

PREVIEW OVERVIEW

At a glance

The report is organised around Origins & History, Genetic Curiosities, Important Clinical Findings and Medication & Pharmacogenomics, followed by supporting evidence, technical traceability and source records.

Origins & History

SYNTHETIC EXAMPLE

Illustrative ancient-DNA reference neighbourhoods and broad modern-reference affinity.

Historical windows are interpreted independently.
No ancestry percentages are implied.

Genetic Curiosities

8 EXAMPLES

Illustrative non-clinical associations covering senses, everyday biology, food response and performance.

Important Clinical Findings

4 SCREENING EXAMPLES

Synthetic cards demonstrate evidence quality, inheritance, confirmation requirements and safety boundaries.

Medication & Pharmacogenomics

5 PGx EXAMPLES

Illustrative coverage-aware gene calls show evaluated, unavailable and specialist-calling states.

Curiosity examples

Synthetic non-clinical associations.

Clinical examples

Synthetic screening presentations.

PGx examples

Illustrative call states.

Real personal results

This preview contains no real DNA analysis.

PREVIEW SCOPE

Selected examples, not a report-size limit

This preview samples the main report surfaces rather than reproducing every possible record. A finished report can contain many more curiosity associations, clinical evidence records, pharmacogenomic evidence items, research-context records and technical provenance entries. The exact number varies with the uploaded DNA file and the evidence that passes the pipeline's quality and safety gates.

SECTION 01

Origins & History

Genome-wide modern reference affinity and dated ancient-DNA reference history, shown here with synthetic examples.

2 example areas

Ancient Origins

Ancient comparisons are shown as affinity to dated reference neighbourhoods within separate historical windows. They are not ancestry percentages and do not claim direct descent from a named archaeological culture.

Upper Palaeolithic European reference neighbourhood

Reference rank 1 · illustrative

In this example, the synthetic sample sits relatively near an Upper Palaeolithic European reference neighbourhood within this chronological window.

Median datec. 28,000 BCE

Reference samples5

StabilityVery stable

Technical interpretation

Distance is model-specific geometry in a fixed PCA space. It is an affinity signal, not a probability or percentage.

Central European Neolithic farming communities

Reference rank 1 · illustrative

This example shows how a later Neolithic reference neighbourhood can appear as the closest stable comparison for its own historical window.

Median datec. 4,200 BCE

Reference samples12

StabilityStable

Historical context

The report can provide short source-backed archaeological context while keeping raw dataset labels and technical provenance behind disclosure.

Central European Bronze Age reference neighbourhood

Reference rank 1 · illustrative

A third synthetic period demonstrates chronological progression without implying that the ancient groups are components that add to 100%.

Median datec. 2,100 BCE

Reference samples16

StabilityStable

Scientific boundary

Each historical window is evaluated independently. Results should be read within that window rather than combined as an ancestry mixture.

Closest Modern References

Northwestern / Central European reference neighbourhood

Broad affinity example

The synthetic sample is shown near a broad modern European reference neighbourhood. DNA_CHECKS stops at the level supported by the reference model rather than inventing fine-scale nationality or ethnicity.

ModelFixed reference PCA

ResolutionBroad regional

Fine scaleWithheld

Why DNA_CHECKS stops here

Fine-scale labels are shown only when reference data, validation and model stability justify that level of specificity.

SECTION 02

Genetic Curiosities

Published non-clinical genetic associations presented as illustrative synthetic trait examples.

8 examples

Bitter taste sensitivity Example

A synthetic TAS2R38-style example showing how DNA_CHECKS explains a non-clinical sensory association, including direction, evidence strength and population limitations.

Illustrative genotypeC/T

EvidenceStrong

CategorySenses

Earwax type Example

A synthetic ABCC11-style example showing how a simple, well-studied everyday trait can be presented without implying clinical importance.

Illustrative genotypeC/T

EvidenceStrong

CategoryEveryday biology

Caffeine response tendency Example

A synthetic example of a common behavioural/physiological association. The report explains that environmental factors and other variants can matter substantially.

Illustrative genotypeA/C

EvidenceModerate

CategoryFood & drink

Muscle-performance association Example

A synthetic ACTN3-style example demonstrating how performance associations are framed as small probabilistic tendencies rather than deterministic predictions.

Illustrative genotypeC/T

EvidenceModerate

CategoryPerformance

Coriander perception Example

A synthetic sensory-preference example showing how DNA_CHECKS separates a published association from a deterministic prediction about what somebody will actually taste or like.

Illustrative genotypeA/G

EvidenceModerate

CategorySenses

Asparagus odour perception Example

A synthetic smell-perception example demonstrating how a small everyday genetic curiosity can be explained alongside study-population and effect-size caveats.

Illustrative genotypeG/G

EvidenceModerate

CategorySenses

Chronotype tendency Example

A synthetic sleep-timing association illustrating how polygenic, lifestyle-sensitive traits are presented as tendencies rather than fixed biological outcomes.

Illustrative genotypeC/T

EvidenceModerate

CategoryEveryday biology

Exercise recovery association Example

A synthetic performance-related association showing how DNA_CHECKS keeps small statistical effects in context and avoids turning them into training prescriptions.

Illustrative genotypeA/A

EvidenceModerate

CategoryPerformance

SECTION 03

Important Clinical Findings

How high-priority clinical screening evidence is presented, using synthetic examples only.

4 examples

Example recessive carrier-pattern finding

Screening only · synthetic

DNA_CHECKS would describe the observed genotype, the relevant inheritance model, the quality and agreement of supporting sources, and why independent clinical confirmation is required before medical use.

Evidence qualityModerate

Clinical finalityScreening only

ConfirmationRequired

What this means

A consumer SNP-array result can be useful for screening, but it is not a diagnosis. Consequential findings require confirmation by an accredited clinical laboratory.

Example clinically relevant variant requiring caution

Evidence under review · synthetic

This example demonstrates a finding that is retained because it may matter, but is not promoted to the highest-priority interpretation when source agreement, penetrance or technical certainty remains incomplete.

Evidence stateConcordant with limitations

Population contextContext only

ActionDo not act on this report alone

Why evidence can be withheld

DNA_CHECKS separates source evidence from genotype certainty and can keep uncertain or conflicting evidence in supporting context instead of overstating it.

Example dominant-inheritance screening finding

Screening only · synthetic

This synthetic example demonstrates how a potentially important dominant-inheritance observation would be separated from lower-priority associations and accompanied by confirmation, penetrance and family-context cautions.

Evidence qualityStrong source evidence

InheritanceDominant example

Clinical actionConfirm before use

Why confirmation remains necessary

Consumer-array data and interpretation are screening tools. A consequential result should be confirmed independently in an accredited clinical setting before medical decisions are made.

Example reduced-penetrance clinical association

Contextual · synthetic

This synthetic example shows how DNA_CHECKS can retain a clinically relevant association while making clear that carrying an associated allele does not mean the condition is present or inevitable.

Evidence qualityModerate

PenetranceIncomplete / context-dependent

PlacementLower prominence

Presentation rule

Evidence that is scientifically relevant but less deterministic is presented with lower prominence and stronger context rather than being promoted as a diagnosis.

SECTION 04

Medication & Pharmacogenomics

Coverage-aware pharmacogenomic presentation with synthetic example calls and explicit safety boundaries.

5 examples

Example personal pharmacogenomic profile

DNA_CHECKS compares observed DNA with pharmacogene definitions, preserves missing positions as unknown and accepts only calls that pass coverage and diplotype safety gates.

Example gene calls accepted3

Withheld for coverageSeveral

Medication changes authorized0

The report distinguishes evaluated personal calls from guideline evidence records. A source database containing many PGx records does not mean the person has that many medication findings.

CYP2C19

Illustrative phenotype

Example presentation of an intermediate-metabolizer-style result when sufficient allele-definition coverage is available.

Call stateEvaluated

PhenotypeIllustrative intermediate metabolizer

GuidanceClinical source context shown separately

Medication boundary

DNA_CHECKS does not instruct the user to start, stop or change a medicine. Genotype-specific guidance is shown only when the evidence gate is satisfied.

SLCO1B1

Illustrative function

Example presentation of a decreased-function-style call with coverage and source provenance exposed for review.

Call stateEvaluated

FunctionIllustrative decreased function

EvidenceCoverage-gated

Source comparison

CPIC, DPWG, ClinPGx and FDA evidence are kept source-specific rather than collapsed into one undifferentiated recommendation.

CYP2D6

Specialist calling required

This example demonstrates a pharmacogene that may be withheld from consumer-array calling when copy-number or complex haplotype resolution is insufficient.

Call stateUnavailable

ReasonComplex locus

Next stepMore complete sequencing / specialist caller

Why unavailable matters

An unavailable result is not treated as normal function. Missing or unresolved data remains explicitly unknown.

CYP2C9

Illustrative phenotype

A synthetic example showing how an accepted metabolizer-style call can be presented alongside coverage information and source-specific clinical guidance.

Call stateEvaluated

PhenotypeIllustrative reduced function

UseContext only

Guideline handling

Guidance remains tied to the relevant clinical source and does not become a universal medication instruction.

TPMT

Illustrative function

A synthetic example showing how DNA_CHECKS can distinguish an evaluated pharmacogene result from loci where consumer-array coverage is insufficient for a safe call.

Call stateEvaluated

FunctionIllustrative intermediate

Evidence gatePassed

Safety boundary

The report does not direct dose changes. Medication decisions remain with an appropriate clinician or pharmacist using confirmed clinical information.

SECTION 05

Further Evidence & Research Context

Lower-priority clinical, risk, protective and uncertain evidence retained for context and transparency.

6 example groups

Risk & susceptibility association

Illustrative association retained for context because the effect is small, population-dependent or not appropriate for a prominent clinical conclusion.

Protective association

Illustrative protective-direction association shown with the same caveats about effect size, population transferability and non-diagnostic meaning.

Evidence requiring caution

An example of conflicting or incomplete evidence that DNA_CHECKS keeps visible for transparency rather than silently discarding or over-promoting.

Additional clinical context

Gene-disease or variant-condition evidence that may be scientifically relevant but does not currently meet the main-report promotion gate.

Population-frequency context

An illustrative evidence card showing how population frequency can contextualise a variant without being treated as proof for or against disease in one individual.

Gene–disease relationship context

An illustrative record showing how gene-level validity evidence can be retained separately from the interpretation of a specific observed genotype.

SECTION 06

Technical Evidence Appendix

Structured provenance and traceability examples illustrating the technical audit layer.

5 example fields

Record	Example value	Purpose
Input source	SYNTHETIC_PREVIEW	Identifies the input class without exposing a personal file.
Genome build	GRCh37 → GRCh38	Documents coordinate normalization.
Evidence state	PREVIEW_ONLY	Prevents illustrative records being confused with real findings.
Evidence fingerprint	example_sha256_not_a_real_run	Shows where deterministic provenance appears in a real report.
Clinical finality	SCREENING_ONLY	Demonstrates the report's explicit clinical boundary.

SECTION 07

Sources, Licensing & Data Use

Representative scientific resources and source roles used by the DNA_CHECKS evidence system.

10 sources shown

ClinVar — variant-level clinical assertions and review status.
ClinGen — gene-disease validity and clinical actionability context.
GenCC — gene-disease relationship assertions.
gnomAD — population allele-frequency context.
CPIC / ClinPGx — pharmacogenomic guideline and allele-definition context.
DPWG — pharmacogenomic guideline context.
NHGRI-EBI GWAS Catalog — curated non-clinical association evidence.
AADR — ancient-DNA reference data used for dated origin comparisons.
HGDP + 1000 Genomes — modern reference modelling.
HPO / MONDO / Orphadata — phenotype and disease ontology context.

METHODOLOGY

Scientific boundaries

A real DNA_CHECKS report is generated from deterministic evidence pipelines. The scientific states, rankings, evidence gates, provenance and safety boundaries are not decided by generative AI.

Consumer SNP-array calls are treated as screening inputs, not clinical diagnoses.
Missing genotype information remains unknown rather than being silently assumed to be reference.
Ancient and modern origins are separate reference-comparison domains, not ancestry percentages.
Pharmacogenomic evidence is coverage-aware and does not authorize medication changes.

DNA_CHECKS · public synthetic preview